Business Context and Reporting Period
This Form 8-K is a current report filed by ReWalk Robotics Ltd. (noting the input metadata reference to "Lifeward Ltd." appears to be an error as the filing explicitly names ReWalk Robotics) on October 13, 2023. The registrant is an emerging growth company incorporated in Israel with its principal executive offices in Yokneam Ilit. The report discloses the furnishing of an investor presentation to the public.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document serves solely to disclose the availability of an investor presentation and does not contain audited or unaudited financial statements.
Material Changes
No material changes to financial performance or operations are reported in this specific filing. The only reported event is the posting of an investor presentation slideshow to the company's website.
Guidance, Outlook, and Risks
The company intends to use the furnished investor presentation for communications with analysts and potential investors. The filing explicitly states that the presentation is furnished pursuant to Regulation FD and is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. Consequently, the presentation is not incorporated by reference into any other filings unless expressly stated. No specific guidance, outlook, or risk factors are detailed within the text of this 8-K.
Investor Verification Checklist
- Verify the content of the Investor Presentation (Exhibit 99.1) referenced in the filing, as the 8-K itself contains no financial data.
- Confirm the company's status as an emerging growth company and its listing on the Nasdaq Stock Market under the symbol RWLK.
- Note that the presentation is not incorporated by reference into this filing, meaning its contents are not legally part of this specific SEC report.
- Check for subsequent filings (e.g., 10-Q or 10-K) to obtain actual financial metrics, as this 8-K does not provide them.